EP Wealth Advisors LLC Makes New Investment in Solventum Co. (NYSE:SOLV)

EP Wealth Advisors LLC purchased a new stake in shares of Solventum Co. (NYSE:SOLV) during the 3rd quarter, HoldingsChannel reports. The firm purchased 5,091 shares of the company’s stock, valued at approximately $355,000.

A number of other large investors have also recently bought and sold shares of the company. Kovitz Investment Group Partners LLC purchased a new stake in Solventum in the 3rd quarter worth approximately $356,000. Worldquant Millennium Advisors LLC increased its position in shares of Solventum by 373.6% during the third quarter. Worldquant Millennium Advisors LLC now owns 47,665 shares of the company’s stock worth $3,323,000 after purchasing an additional 37,600 shares in the last quarter. Weiss Asset Management LP acquired a new stake in shares of Solventum in the third quarter valued at about $2,292,000. State Street Corp lifted its stake in Solventum by 3.1% in the 3rd quarter. State Street Corp now owns 6,107,550 shares of the company’s stock worth $425,818,000 after purchasing an additional 185,938 shares in the last quarter. Finally, Quantinno Capital Management LP purchased a new position in Solventum during the third quarter worth approximately $448,000.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on SOLV shares. Morgan Stanley lifted their target price on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. Mizuho started coverage on Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price for the company. Wolfe Research initiated coverage on shares of Solventum in a report on Thursday, September 26th. They set a “peer perform” rating on the stock. Piper Sandler lifted their price objective on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Finally, Stifel Nicolaus began coverage on Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price on the stock. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $68.29.

Solventum Trading Down 0.7 %

SOLV opened at $70.01 on Friday. The business’s 50 day moving average is $70.82 and its two-hundred day moving average is $63.08. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.